{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:43:08Z","timestamp":1790815388244,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006532","name":"eNeura Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001436"],"award-info":[{"award-number":["UL1TR001436"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 DK099201-01A1"],"award-info":[{"award-number":["RO1 DK099201-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.neuropharm.2017.08.023","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T06:31:02Z","timestamp":1503037862000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Analgesic effect of ADX71441, a positive allosteric modulator (PAM) of GABAB receptor in a rat model of bladder pain"],"prefix":"10.1016","volume":"126","author":[{"given":"Pradeep","family":"Kannampalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia-Maria","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Bol\u00e9a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti N.","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.08.023_bib1","first-page":"732","article-title":"Inflammation-induced shift in the valence of spinal GABA-A receptor-mediated modulation of nociception in the adult rat","volume":"8","author":"Anseloni","year":"2008","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/npp.2017.53","article-title":"The GABAB positive allosteric modulator, ADX71441 attenuates alcohol self-administration and relapse to alcohol seeking in rats","volume":"42","author":"Augier","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1043-6618(02)00147-0","article-title":"Baclofen analgesia: involvement of the GABAergic system","volume":"46","author":"Balerio","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib4","first-page":"99","article-title":"Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review","volume":"5","author":"Brennan","year":"2013","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/02688690802233364","article-title":"Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain","volume":"22","author":"Brennan","year":"2008","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coph.2005.10.002","article-title":"GABAB receptor: a site of therapeutic benefit","volume":"6","author":"Bowery","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-8993(95)00262-O","article-title":"Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy","volume":"679","author":"Castro-Lopes","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib8","first-page":"638","article-title":"Interstitial cystitis\/bladder pain syndrome and glycosaminoglycans replacement therapy","volume":"4","author":"Cervigni","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib9","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/ar.22506","article-title":"Comparison of three methods of drug delivery in the rat lumbar spinal subarachnoid space","volume":"295","author":"Chen","year":"2012","journal-title":"Anat. Rec. Hob."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/jog.12932","article-title":"Clinical and urodynamic effects of baclofen in women with functional bladder outlet obstruction: preliminary report","volume":"42","author":"Chen","year":"2016","journal-title":"J.\u00a0Obstet. Gynaecol. Res."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrd746","article-title":"Allosteric binding sites on cell-surface receptors: novel targets for drug discovery","volume":"1","author":"Christopoulos","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/ner.12361","article-title":"Intrathecal baclofen dosing regimens: a retrospective chart review","volume":"19","author":"Clearfield","year":"2016","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib13","first-page":"1390","article-title":"BACH Survey Investigators. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women","volume":"177","author":"Clemens","year":"2007","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2760","article-title":"Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders","volume":"8","author":"Conn","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib15","first-page":"587","article-title":"Orthosteric- and allosteric-induced ligand-directed trafficking at GPCRs","volume":"13","author":"Digby","year":"2010","journal-title":"Curr. Opin. Drug Discov. Devel"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(25)12039-9","article-title":"Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model","volume":"275","author":"Dirig","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1545968309343213","article-title":"Management of spasticity after spinal cord injury: current techniques and future directions","volume":"24","author":"Elbasiouny","year":"2010","journal-title":"Neurorehabil. Neural. Repair"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(06)54001-3","article-title":"The role of GABA in the mediation and perception of pain","volume":"54","author":"Enna","year":"2006","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib19","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.ddtec.2012.10.007","article-title":"Allosteric modulation of Class C GPCRs: a novel approach for the treatment of CNS disorders","volume":"10","author":"Engers","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib20","first-page":"S28","article-title":"Painful bladder syndrome and interstitial cystitis: treatment options","volume":"22","author":"Fiander","year":"2013","journal-title":"Br. J. Nurs."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1517\/13543776.2010.506480","article-title":"Novel GABA(B) receptor positive modulators: a patent survey","volume":"20","author":"Froestl","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eururo.2011.07.069","article-title":"Contemporary management of the painful bladder: a systematic review","volume":"61","author":"Giannantoni","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib23","first-page":"203","article-title":"Summary of the national institute of Arthritis,Diabetes, digestive and kidney diseases workshop on interstitial Cystitis,National Institutes of Health, bethesda, Maryland, august 28-29, 1987","volume":"140","author":"Gillenwater","year":"1988","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1090-3801(97)90067-7","article-title":"GABA-receptor control of the amplitude and duration of the neuronal responses to formalin in the rat spinal cord","volume":"1","author":"Green","year":"1997","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-013-3245-z","article-title":"Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice","volume":"231","author":"Hwa","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib26","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1111\/bph.12617","article-title":"GABAB receptors in the bladder and bowel: therapeutic potential for positive allosteric modulators?","volume":"172","author":"Hyland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/1568007043336716","article-title":"GABA puts a stop to pain","volume":"3","author":"Jasmin","year":"2004","journal-title":"Curr. Drug Targets CNS. Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/bph.12517","article-title":"ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder","volume":"171","author":"Kalinichev","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2016.11.016","article-title":"The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABA(B) receptor with a potential for treatment of anxiety, pain and spasticity","volume":"114","author":"Kalinichev","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2016.11.056","article-title":"ADX71943 and ADX71441, novel positive allosteric modulators of the GABA(B) receptor with distinct central\/peripheral profiles, show efficacy in the monosodium iodoacetate model of chronic osteoarthritis pain in the rat","volume":"795","author":"Kalinichev","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2017.01.021","article-title":"Neonatal bladder inflammation induces long-term visceral pain and altered responses of spinal neurons in adult rats","volume":"346","author":"Kannampalli","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0021-5198(19)43345-3","article-title":"The effect of baclofen on the urinary bladder contraction accompanying micturition in anesthetized rats","volume":"46","author":"Kontani","year":"1988","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/187152710790966614","article-title":"Effectiveness and safety of baclofen in the treatment of alcohol dependent patients","volume":"9","author":"Leggio","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib35","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1152\/jn.1996.76.2.1005","article-title":"Inhibition of primate spinothalamic tract neurons by spinal glycine and GABA is reduced during central sensitization","volume":"76","author":"Lin","year":"1996","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib36","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0028-3908(99)00121-5","article-title":"Nociceptive regulation of GABA(B) receptor gene expression in rat spinal cord","volume":"38","author":"McCarson","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib37","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1007\/s11064-014-1254-x","article-title":"GABA pharmacology: the search for analgesics","volume":"39","author":"McCarson","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib38","first-page":"1178","article-title":"GABA receptor activation in the lumbosacral spinal cord decreases detrusor over activity in spinal cord injured rats","volume":"179","author":"Miyazato","year":"2008","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/11597320-000000000-00000","article-title":"Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence","volume":"26","author":"Muzyk","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1527-3458.2005.tb00049.x","article-title":"Clinical potential of GABAB receptor modulators","volume":"11","author":"Ong","year":"2005","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib41","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00000542-200305000-00026","article-title":"GABAergic interneurons at supraspinal and spinal levels differentially modulate the antinociceptive effect of nitrous oxide in Fischer rats","volume":"98","author":"Orii","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib42","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1523\/JNEUROSCI.19-19-08597.1999","article-title":"GABA(B) receptors inhibit mechanosensitivity of primary afferent endings","volume":"19","author":"Page","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/157015907781695919","article-title":"Allosteric modulators of GABA(B) receptors: mechanism of action and therapeutic perspective","volume":"5","author":"Pin","year":"2007","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1474-8673.2002.00254.x","article-title":"GABA(B) receptor function in the ileum and urinary bladder of wildtype and GABA(B1) subunit null mice","volume":"22","author":"Sanger","year":"2002","journal-title":"Auton. Autacoid. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0091-3057(87)90148-1","article-title":"GABAergic mechanisms of analgesia: an update","volume":"26","author":"Sawynok","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib52","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1152\/jn.1994.72.5.2420","article-title":"Mechanosensitive properties of pelvic nerve afferent fibers innervating the urinary bladder of the rat","volume":"72","author":"Sengupta","year":"1994","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib46","doi-asserted-by":"crossref","first-page":"G1343","DOI":"10.1152\/ajpgi.00124.2002","article-title":"Effect of GABA(B) receptor agonist on distension-sensitive pelvic nerve afferent fibers innervating rat colon","volume":"283","author":"Sengupta","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/15563650.2011.654209","article-title":"Baclofen overdose mimicking brain death","volume":"50","author":"Sullivan","year":"2012","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/pr.109.002501","article-title":"Allosteric modulation of G-protein-coupled receptors: from molecular insights to therapeutic perspectives","volume":"63","author":"Urwyler","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2017.08.023_bib49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/082585971302900108","article-title":"Intravesical baclofen, bupivacaine, and oxycodone for the relief of bladder spasm","volume":"29","author":"Wallace","year":"2013","journal-title":"J.\u00a0Palliat. Care"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuroscience.2012.04.026","article-title":"GABA(B) receptor-mediated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline","volume":"213","author":"Whitehead","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.08.023_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2016.04.028","article-title":"The positive allosteric GABAB receptor modulator rac-BHFF enhances baclofen-mediated analgesia in neuropathic mice","volume":"108","author":"Zemoura","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:35:50Z","timestamp":1777426550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817303908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":51,"alternative-id":["S0028390817303908"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.023","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesic effect of ADX71441, a positive allosteric modulator (PAM) of GABAB receptor in a rat model of bladder pain","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}